DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients treated on clinical trials

被引:0
|
作者
Tran, Q. [1 ]
Upadhyaya, S. [2 ]
Billups, C. [1 ]
Onar-Thomas, A. [1 ]
Carey, S. [1 ]
Alom, M. [1 ]
Robinson, G. [1 ]
Ellison, D. [1 ]
Gajjar, A. [1 ]
Orr, B. [1 ]
机构
[1] St Jude Childrens Res Hosp, Memphis, TN USA
[2] Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
131
引用
收藏
页码:544 / 544
页数:1
相关论文
共 50 条
  • [21] Clinical significance of tumor suppressor genes methylation in circulating tumor DNA of patients with pancreatic cancer
    Xin, Wanpeng
    Tu, Shuju
    Yi, Siqing
    Xiong, Yuanpeng
    Fang, Kang
    Sun, Gen
    Xiao, Weidong
    GENE, 2024, 897
  • [22] PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients
    Napieralski, Rudolf
    Schricker, Gabriele
    Auer, Gert
    Aubele, Michaela
    Perkins, Jonathan
    Magdolen, Viktor
    Ulm, Kurt
    Hamann, Moritz
    Walch, Axel
    Weichert, Wilko
    Kiechle, Marion
    Wilhelm, Olaf G.
    BREAST CARE, 2021, 16 (05) : 523 - 531
  • [23] Clinical parameters vs MGMT methylation as prognostic factors in unselected radiation-treated GBM patients
    Nowicka, E.
    Jarzab, M.
    Gawkowska-Suwinska, M.
    Stanek-Widera, A.
    Straczynska-Niemiec, A.
    Cichon, T.
    Lange, D.
    Szala, S.
    Bobek-Billewicz, B.
    Tarnawski, R.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S9 - S9
  • [24] Immunohistochemical detection of EGFRvIII and prognostic significance in patients with malignant glioma enrolled in NCCTG clinical trials.
    Buckner, JC
    Aldape, KD
    Ballman, K
    Scheithauer, BW
    Burger, PC
    Giannini, C
    Schaefer, PL
    Jenkins, RB
    James, CD
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 109S - 109S
  • [25] Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients
    Nidhi Singh
    Sumaira Rashid
    Safoora Rashid
    Nihar Ranjan Dash
    Surabhi Gupta
    Anoop Saraya
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 897 - 907
  • [26] Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients
    Singh, Nidhi
    Rashid, Sumaira
    Rashid, Safoora
    Dash, Nihar Ranjan
    Gupta, Surabhi
    Saraya, Anoop
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (04) : 897 - 907
  • [27] Efficacy in Predefined Subgroups of Patients with Chronic Cough Treated with Gefapixant in Two Phase 3 Randomized Controlled Clinical Trials
    Mcgarvey, L.
    Birring, S. S.
    Dicpinigaitis, P.
    Morice, A. H.
    Pavord, I. D.
    Smith, J.
    Iskold, B.
    Li, Q.
    Tzontcheva, A.
    Muccino, D.
    La Rosa, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [28] Prognostic and clinical significance of subcellular CDC27 for patients with rectal adenocarcinoma treated with adjuvant chemotherapy
    Chang, Chia-Lin
    Huang, Kevin Chih-Yang
    Chen, Tsung-Wei
    Chen, William Tzu-Liang
    Huang, Hsuan-Hua
    Liu, Ya-Ling
    Kuo, Chia-Hui
    Chao, K. S. Clifford
    Ke, Tao-Wei
    Chiang, Shu-Fen
    ONCOLOGY LETTERS, 2022, 24 (01)
  • [29] Clinical Importance of DNA Methylation Signatures in Chronic Lymphocytic Leukaemia Patients Treated with Chemo-Immunotherapy
    Amarasinghe, Harindra
    Wojdacz, Tomasz K.
    Rose-Zerilli, Matthew John Jerome
    Beattie, Alice
    Forster, Jade
    Kadalayil, Latha
    Blakemore, Stuart
    Parker, Helen
    Larrayoz, Marta
    Clifford, Ruth
    Davis, Zadie
    Else, Monica
    Cohen, Dena
    Steele, Andrew J.
    Rosenquist, Richard
    Collins, Andrew
    Pettitt, Andrew
    Hillmen, Peter
    Robbe, Pauline
    Plass, Christopher
    Schuh, Anna
    Catovsky, Daniel
    Oscier, David
    Oakes, Christopher C.
    Strefford, Jonathan C.
    BLOOD, 2017, 130
  • [30] The clinical importance of DNA methylation signatures in chronic lymphocytic leukemia patients treated with chemo-immunotherapy
    Wojdacz, Tomasz K.
    Amarasinghe, Harindra E.
    Rose-Zerilli, Matthew J. J.
    Beattie, Alice
    Forster, Jade
    Kadalayil, Latha
    Blakemore, Stuart
    Parker, Helen
    Larrayoz, Marta
    Clifford, Ruth
    Davis, Zadie
    Else, Monica
    Cohen, Dena
    Steele, Andrew J.
    Rosenquist, Richard
    Collins, Andrew
    Pettitt, Andrew
    Hillmen, Peter
    Plass, Christoph
    Schuh, Anna
    Catovsky, Daniel
    Oscier, David G.
    Oakes, Christopher C.
    Strefford, Jonathan C.
    CANCER RESEARCH, 2018, 78 (13)